These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


198 related items for PubMed ID: 30038042

  • 1. Effects of Phage Endolysin SAL200 Combined with Antibiotics on Staphylococcus aureus Infection.
    Kim NH, Park WB, Cho JE, Choi YJ, Choi SJ, Jun SY, Kang CK, Song KH, Choe PG, Bang JH, Kim ES, Park SW, Kim NJ, Oh MD, Kim HB.
    Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30038042
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of Intranasal Administration of the Recombinant Endolysin SAL200 in a Lethal Murine Staphylococcus aureus Pneumonia Model.
    Bae JY, Jun KI, Kang CK, Song KH, Choe PG, Bang JH, Kim ES, Park SW, Kim HB, Kim NJ, Park WB, Oh MD.
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30670417
    [Abstract] [Full Text] [Related]

  • 3. Antibacterial properties of a pre-formulated recombinant phage endolysin, SAL-1.
    Jun SY, Jung GM, Yoon SJ, Oh MD, Choi YJ, Lee WJ, Kong JC, Seol JG, Kang SH.
    Int J Antimicrob Agents; 2013 Feb; 41(2):156-61. PubMed ID: 23276502
    [Abstract] [Full Text] [Related]

  • 4. Pharmacokinetics of the phage endolysin-based candidate drug SAL200 in monkeys and its appropriate intravenous dosing period.
    Jun SY, Jung GM, Yoon SJ, Youm SY, Han HY, Lee JH, Kang SH.
    Clin Exp Pharmacol Physiol; 2016 Oct; 43(10):1013-6. PubMed ID: 27341401
    [Abstract] [Full Text] [Related]

  • 5. Efficacy of chimeric ectolysin P128 in drug-resistant Staphylococcus aureus bacteraemia in mice.
    Channabasappa S, Chikkamadaiah R, Durgaiah M, Kumar S, Ramesh K, Sreekanthan A, Sriram B.
    J Antimicrob Chemother; 2018 Dec 01; 73(12):3398-3404. PubMed ID: 30215762
    [Abstract] [Full Text] [Related]

  • 6. P-27/HP endolysin as antibacterial agent for antibiotic resistant Staphylococcus aureus of human infections.
    Gupta R, Prasad Y.
    Curr Microbiol; 2011 Jul 01; 63(1):39-45. PubMed ID: 21519800
    [Abstract] [Full Text] [Related]

  • 7. RNAIII-inhibiting peptide improves efficacy of clinically used antibiotics in a murine model of staphylococcal sepsis.
    Giacometti A, Cirioni O, Ghiselli R, Dell'Acqua G, Orlando F, D'Amato G, Mocchegiani F, Silvestri C, Del Prete MS, Rocchi M, Balaban N, Saba V, Scalise G.
    Peptides; 2005 Feb 01; 26(2):169-75. PubMed ID: 15629527
    [Abstract] [Full Text] [Related]

  • 8. Restoration of sensitivity of a diverse set of drug-resistant Staphylococcus clinical strains by bactericidal protein P128.
    Nair S, Poonacha N, Desai S, Hiremath D, Tuppad D, Mohan T, Chikkamadaiah R, Durgaiah M, Kumar S, Channabasappa S, Vipra A, Sharma U.
    J Med Microbiol; 2018 Mar 01; 67(3):296-307. PubMed ID: 29458674
    [Abstract] [Full Text] [Related]

  • 9. LysSYL: a broad-spectrum phage endolysin targeting Staphylococcus species and eradicating S. aureus biofilms.
    Liu H, Wei X, Wang Z, Huang X, Li M, Hu Z, Zhang K, Hu Q, Peng H, Shang W, Yang Y, Wang Y, Lu S, Rao X.
    Microb Cell Fact; 2024 Mar 25; 23(1):89. PubMed ID: 38528536
    [Abstract] [Full Text] [Related]

  • 10. Efficacy of Novel Antistaphylococcal Ectolysin P128 in a Rat Model of Methicillin-Resistant Staphylococcus aureus Bacteremia.
    Channabasappa S, Durgaiah M, Chikkamadaiah R, Kumar S, Joshi A, Sriram B.
    Antimicrob Agents Chemother; 2018 Feb 25; 62(2):. PubMed ID: 29180523
    [Abstract] [Full Text] [Related]

  • 11. Synergistic effect of linezolid with fosfomycin against Staphylococcus aureus in vitro and in an experimental Galleria mellonella model.
    Li L, Chen H, Liu Y, Xu S, Wu M, Liu Z, Qi C, Zhang G, Li J, Huang X.
    J Microbiol Immunol Infect; 2020 Oct 25; 53(5):731-738. PubMed ID: 30638785
    [Abstract] [Full Text] [Related]

  • 12. Randomized Multicenter Study Comparing Safety and Efficacy of Daptomycin Versus Standard-of-care in Pediatric Patients With Staphylococcal Bacteremia.
    Arrieta AC, Bradley JS, Popejoy MW, Bensaci M, Grandhi A, Bokesch P, Glasser C, Du L, Patino H, Kartsonis NA.
    Pediatr Infect Dis J; 2018 Sep 25; 37(9):893-900. PubMed ID: 29406465
    [Abstract] [Full Text] [Related]

  • 13. Cefazolin and Ertapenem, a Synergistic Combination Used To Clear Persistent Staphylococcus aureus Bacteremia.
    Sakoulas G, Olson J, Yim J, Singh NB, Kumaraswamy M, Quach DT, Rybak MJ, Pogliano J, Nizet V.
    Antimicrob Agents Chemother; 2016 Nov 25; 60(11):6609-6618. PubMed ID: 27572414
    [Abstract] [Full Text] [Related]

  • 14. RNAIII-inhibiting peptide significantly reduces bacterial load and enhances the effect of antibiotics in the treatment of central venous catheter-associated Staphylococcus aureus infections.
    Cirioni O, Giacometti A, Ghiselli R, Dell'Acqua G, Orlando F, Mocchegiani F, Silvestri C, Licci A, Saba V, Scalise G, Balaban N.
    J Infect Dis; 2006 Jan 15; 193(2):180-6. PubMed ID: 16362881
    [Abstract] [Full Text] [Related]

  • 15. Impact of an assay that enables rapid determination of Staphylococcus species and their drug susceptibility on the treatment of patients with positive blood culture results.
    Parta M, Goebel M, Thomas J, Matloobi M, Stager C, Musher DM.
    Infect Control Hosp Epidemiol; 2010 Oct 15; 31(10):1043-8. PubMed ID: 20731594
    [Abstract] [Full Text] [Related]

  • 16. Pharmacokinetics and Tolerance of the Phage Endolysin-Based Candidate Drug SAL200 after a Single Intravenous Administration among Healthy Volunteers.
    Jun SY, Jang IJ, Yoon S, Jang K, Yu KS, Cho JY, Seong MW, Jung GM, Yoon SJ, Kang SH.
    Antimicrob Agents Chemother; 2017 Jun 15; 61(6):. PubMed ID: 28348152
    [Abstract] [Full Text] [Related]

  • 17. Daptomycin versus placebo as an adjunct to beta-lactam therapy in the treatment of Staphylococcus aureus bacteremia: study protocol for a randomized controlled trial.
    Cheng MP, Lawandi A, Butler-Laporte G, Paquette K, Lee TC.
    Trials; 2018 May 29; 19(1):297. PubMed ID: 29843781
    [Abstract] [Full Text] [Related]

  • 18. Identification of Peptidoglycan Hydrolase Constructs with Synergistic Staphylolytic Activity in Cow's Milk.
    Verbree CT, Dätwyler SM, Meile S, Eichenseher F, Donovan DM, Loessner MJ, Schmelcher M.
    Appl Environ Microbiol; 2017 Apr 01; 83(7):. PubMed ID: 28159785
    [Abstract] [Full Text] [Related]

  • 19. Synergy between the phage endolysin LysH5 and nisin to kill Staphylococcus aureus in pasteurized milk.
    García P, Martínez B, Rodríguez L, Rodríguez A.
    Int J Food Microbiol; 2010 Jul 15; 141(3):151-5. PubMed ID: 20537744
    [Abstract] [Full Text] [Related]

  • 20. Experimental study on the efficacy of combinations of glycopeptides and beta-lactams against Staphylococcus aureus with reduced susceptibility to glycopeptides.
    Domenech A, Ribes S, Cabellos C, Taberner F, Tubau F, Domínguez MA, Montero A, Liñares J, Ariza J, Gudiol F.
    J Antimicrob Chemother; 2005 Oct 15; 56(4):709-16. PubMed ID: 16120625
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.